Detalhe da pesquisa
1.
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Brain Behav Immun
; 91: 369-382, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33223048
2.
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Acta Neuropathol
; 138(2): 251-273, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31006066
3.
Correction to: Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Acta Neuropathol
; 145(4): 509-510, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36790609
4.
Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.
Brain
; 140(1): 98-117, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27807026
5.
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Neurobiol Dis
; 106: 279-290, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736195
6.
Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
J Parkinsons Dis
; 14(4): 693-711, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728204
7.
Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson's disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration.
Front Aging Neurosci
; 16: 1337365, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38374883
8.
Reply: Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.
Brain
; 140(6): e33, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379295
9.
Low prevalence of known pathogenic mutations in dominant PD genes: A Swedish multicenter study.
Parkinsonism Relat Disord
; 66: 158-165, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31422003
10.
Glutathione S-Transferase Alpha 4 Prevents Dopamine Neurodegeneration in a Rat Alpha-Synuclein Model of Parkinson's Disease.
Front Neurol
; 9: 222, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29681884
11.
Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response.
Front Cell Neurosci
; 12: 488, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30618635
12.
Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson's Disease.
Brain Sci
; 7(7)2017 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-28672859
13.
Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson's Disease.
Sci Rep
; 6: 31701, 2016 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27550741